Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex!

× No keyword cloud information.

11 in total

1. Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?

Authors: Richard M Goldberg
Journal: Oncologist Date: 2015-10-28

Review 2. Integration of molecular pathology, epidemiology and social science for global precision medicine.

Authors: Akihiro Nishi; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Andy S Tan; Ichiro Kawachi; Shuji Ogino
Journal: Expert Rev Mol Diagn Date: 2015-12-04 Impact factor: 5.225

Review 3. Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review.

Authors: Henry T Lynch; Kristen Drescher; Joseph Knezetic; Stephen Lanspa
Journal: Curr Treat Options Oncol Date: 2014-09

4. Phospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effect.

Authors: Liqun Huang; Chi C Wong; Ka W Cheng; Basil Rigas
Journal: PLoS One Date: 2014-11-04 Impact factor: 3.240

5. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.

Authors: Cui Chen; Peng Sun; Qiang-sheng Dai; Hui-wen Weng; He-ping Li; Sheng Ye
Journal: PLoS One Date: 2014-11-13 Impact factor: 3.240

6. Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin.

Authors: Sanja B Turturro; Matthew S Najor; Carl E Ruby; Melody A Cobleigh; Abde M Abukhdeir
Journal: Breast Cancer Res Treat Date: 2016-02-25 Impact factor: 4.872

7. Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.

Authors: Ying-Sheng Wen; Ling Cai; Xue-Wen Zhang; Jian-Fei Zhu; Zi-Chen Zhang; Jian-Yong Shao; Lan-Jun Zhang
Journal: Medicine (Baltimore) Date: 2014-12 Impact factor: 1.889

8. The aspirin metabolite salicylate inhibits lysine acetyltransferases and MUC1 induced epithelial to mesenchymal transition.

Authors: Harvey R Fernandez; Sara K Lindén
Journal: Sci Rep Date: 2017-07-17 Impact factor: 4.379

Review 9. New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkers.

Authors: Karen Brown; Alessandro Rufini
Journal: Ecancermedicalscience Date: 2015-11-24

Review 10. Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies.

Authors: Simonetta M Leto; Livio Trusolino
Journal: J Mol Med (Berl) Date: 2014-05-10 Impact factor: 4.599